UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells

Biomaterials, 2011-10, Vol.32 (28), p.6791-6803

2011

Volltextzugriff (PDF)

Targeting dendritic cells—why bother?

Blood, 2013-04, Vol.121 (15), p.2836-2844

2013

Volltextzugriff (PDF)

Targeting Nanoparticles to Dendritic Cells for Immunotherapy

Methods in Enzymology, 2012, Vol.509, p.143-163

2012

Volltextzugriff (PDF)

Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation

Blood, 2011-10, Vol.118 (15), p.4111-4119

2011

Volltextzugriff (PDF)

Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN

Biomaterials, 2012-06, Vol.33 (16), p.4229-4239

2012

Volltextzugriff (PDF)

ICAM3-Fc Outperforms Receptor-Specific Antibodies Targeted Nanoparticles to Dendritic Cells for Cross-Presentation

Molecules (Basel, Switzerland), 2019-05, Vol.24 (9), p.1825

2019

Volltextzugriff (PDF)

Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines

Seminars in immunology, 2011-02, Vol.23 (1), p.12-20

2011

Volltextzugriff (PDF)

Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro

Journal of controlled release, 2010-06, Vol.144 (2), p.118-126

2010

Volltextzugriff (PDF)

Controlled release of antigen and Toll-like receptor ligands from PLGA nanoparticles enhances immunogenicity

Nanomedicine (London, England), 2017-03, Vol.12 (5), p.491-510

2017

Volltextzugriff (PDF)

Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production

Blood, 2008-04, Vol.111 (8), p.4245-4253

2008

Volltextzugriff (PDF)

Protection from obesity in mice lacking the VLDL receptor

Arteriosclerosis, thrombosis, and vascular biology, 2001-09, Vol.21 (9), p.1488

2001

Volltextzugriff (PDF)

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody

Blood, 2005-08, Vol.106 (4), p.1278-1285

2005

Volltextzugriff (PDF)

Targeting antigens to dendritic cells in vivo

Immunobiology (1979), 2006-01, Vol.211 (6), p.599-608

2006

Volltextzugriff (PDF)

Multimodal Imaging of Nanovaccine Carriers Targeted to Human Dendritic Cells

Molecular pharmaceutics, 2011-04, Vol.8 (2), p.520-531

2011

Volltextzugriff (PDF)

Effective Targeting of Pathogens to Neutrophils via Chimeric Surfactant Protein D/Anti-CD89 Protein

The Journal of immunology (1950), 2004-04, Vol.172 (8), p.4934-4940

2004

Volltextzugriff (PDF)

Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus

American journal of physiology. Lung cellular and molecular physiology, 2005-10, Vol.289 (4), p.L606-L616

2005

Volltextzugriff (PDF)

Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters

Cancer Immunology, Immunotherapy, 2012-11, Vol.61 (11), p.2003-2011

2012

Volltextzugriff (PDF)

Monocyte CD64 or CD89 targeting by surfactant protein D/anti‐Fc receptor mediates bacterial uptake

Immunology, 2006-04, Vol.117 (4), p.494-501

2006

Volltextzugriff (PDF)

VLDL receptor deficiency enhances intimal thickening after vascular injury but does not affect atherosclerotic lesion area

Atherosclerosis, 2002-05, Vol.162 (1), p.103-110

2002

Volltextzugriff (PDF)

Living up to a name: the role of the VLDL receptor in lipid metabolism

Current opinion in lipidology, 2001-06, Vol.12 (3), p.275-279

2001

Volltextzugriff (PDF)

Modulating effects of thyroid state on the induction of biotransformation enzymes by 2,3,7,8-tetrachlorodibenzo- p-dioxin

Environmental toxicology and pharmacology, 1998, Vol.5 (1), p.7-16

1998

Volltextzugriff (PDF)

Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus

American journal of physiology. Lung cellular and molecular physiology, 2005-10, Vol.33 (4), p.L606-L616

2005

Volltextzugriff (PDF)

Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E

Biochemical journal, 2000-04, Vol.347 (Pt 2), p.357-361

2000

Volltextzugriff (PDF)

Effective generation of very low density lipoprotein receptor transgenic mice by overlapping genomic DNA fragments: high testis expression and disturbed spermatogenesis

Transgenic research, 2001-06, Vol.10 (3), p.211-221

2001

Volltextzugriff (PDF)

Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E

Biochemical journal, 2000-04, Vol.347 (2), p.357-361

2000

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

ThemaCells, Cultured

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(34)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells

Targeting dendritic cells—why bother?

Targeting Nanoparticles to Dendritic Cells for Immunotherapy

Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation

Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN

ICAM3-Fc Outperforms Receptor-Specific Antibodies Targeted Nanoparticles to Dendritic Cells for Cross-Presentation

Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines

Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro

Controlled release of antigen and Toll-like receptor ligands from PLGA nanoparticles enhances immunogenicity

Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production

Protection from obesity in mice lacking the VLDL receptor

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody

Targeting antigens to dendritic cells in vivo

Multimodal Imaging of Nanovaccine Carriers Targeted to Human Dendritic Cells

Effective Targeting of Pathogens to Neutrophils via Chimeric Surfactant Protein D/Anti-CD89 Protein

Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus

Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters

Monocyte CD64 or CD89 targeting by surfactant protein D/anti‐Fc receptor mediates bacterial uptake

VLDL receptor deficiency enhances intimal thickening after vascular injury but does not affect atherosclerotic lesion area

Living up to a name: the role of the VLDL receptor in lipid metabolism

Modulating effects of thyroid state on the induction of biotransformation enzymes by 2,3,7,8-tetrachlorodibenzo- p-dioxin

Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus

Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E

Effective generation of very low density lipoprotein receptor transgenic mice by overlapping genomic DNA fragments: high testis expression and disturbed spermatogenesis

Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E

Aktive Filter

Suchergebnisse filtern